Bonk (NASDAQ:BNKK) Director Acquires 11,659 Shares of Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy bought 11,659 shares of the stock in a transaction dated Thursday, July 2nd. The stock was purchased at an average cost of $1.47 per share, for a total transaction of $17,138.73. Following the acquisition, the director owned 85,000 shares of the company’s stock, valued at approximately $124,950. This represents a 15.90% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Mitchell Austin Rudy also recently made the following trade(s):

• On Monday, June 22nd, Mitchell Austin Rudy purchased 7,500 shares of Bonk stock. The shares were purchased at an average cost of $1.56 per share, with a total value of $11,700.00.
• On Tuesday, June 16th, Mitchell Austin Rudy acquired 2,500 shares of Bonk stock. The stock was purchased at an average price of $1.32 per share, with a total value of $3,300.00.
• On Wednesday, June 10th, Mitchell Austin Rudy acquired 12,000 shares of Bonk stock. The stock was acquired at an average cost of $1.37 per share, for a total transaction of $16,440.00.
• On Thursday, April 9th, Mitchell Austin Rudy bought 31,055 shares of Bonk stock. The shares were acquired at an average price of $2.82 per share, for a total transaction of $87,575.10.

Bonk Stock Down 6.1%

Shares of Bonk stock traded down $0.09 during trading on Tuesday, reaching $1.39. The company’s stock had a trading volume of 152,991 shares, compared to its average volume of 841,628. The business has a 50 day moving average price of $1.87 and a 200-day moving average price of $2.80. Bonk, Inc. has a 12-month low of $1.25 and a 12-month high of $46.90. The company has a market capitalization of $11.12 million, a P/E ratio of -0.30 and a beta of 1.89.

Bonk (NASDAQ:BNKK) last released its earnings results on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. The business had revenue of $0.79 million during the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. Wall Street Zen raised shares of Bonk from a “sell” rating to a “hold” rating in a report on Saturday. Weiss Ratings downgraded shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Geode Capital Management LLC purchased a new stake in shares of Bonk in the 4th quarter worth about $128,000. Jane Street Group LLC acquired a new position in Bonk during the fourth quarter worth about $96,000. Steward Partners Investment Advisory LLC acquired a new position in Bonk during the fourth quarter worth about $37,000. Finally, State Street Corp purchased a new stake in shares of Bonk in the fourth quarter valued at about $33,000. Institutional investors and hedge funds own 12.55% of the company’s stock.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.